To provide evidence for the direct role of histone methyltransferase activity in the repression observed at the Targeted Histone Methyltransferase Domains endogenous VEGF-A locus, we first confirmed that the Repress Gene Expression In Vivo ZFP domain chimeras were catalytically active in vitro. To determine whether methylation of the histone tails HA epitope-tagged ZFP-HMTs were immunoprecipiis causative in the process of gene repression, we linked tated from transfected cell extracts and were assayed the catalytic HMT activities of both SUV39H1 and G9A for HMT activity. Figure 2A 
and GFP). Thus, direct recruitment repression, we have employed engineered zinc-finger of HMT domains results in the transcriptional repression transcription factors (ZFPs) to target HMT activity to
of the targeted gene in vivo. Interestingly, however, neia specific endogenous gene. By utilizing ZFPs that ther G9A, SUV39H1, nor v-ErbA ZFP fusion proteins recognize the promoter of the endogenous VEGF-A were able to effectively repress a transiently transfected gene [12] , and thus employing this chromosomal locus luciferase reporter plasmid containing the VEGF-A gene as an in vivo reporter, we show that ZFPs linked to a promoter ( Figure 1C and [15] ), although significant minimal catalytic HMT domain affect local methylation upregulation of luciferase activity was observed when of histone H3K9 and the consequent repression of equivalent amounts of ZFP-A fused to the p65 activation target gene expression. Furthermore, amino acid subdomain was used ( Figure 1C ). This result supports the stitutions within the HMT that ablate its catalytic activchromatin-specific mode of repression expected for the ity [6] effectively eliminate the ability of the ZFP fusions ZFP-HMTs and highlights the utility of assays employing to repress transcription. Thus, H3K9 methylation is a endogenous genes. primary signal that is sufficient for initiating a gene repression pathway in vivo.
HMT Activity Is Necessary for Gene Repression Results
To provide evidence for the direct role of histone methyltransferase activity in the repression observed at the Targeted Histone Methyltransferase Domains endogenous VEGF-A locus, we first confirmed that the Repress Gene Expression In Vivo ZFP domain chimeras were catalytically active in vitro. To determine whether methylation of the histone tails HA epitope-tagged ZFP-HMTs were immunoprecipiis causative in the process of gene repression, we linked tated from transfected cell extracts and were assayed the catalytic HMT activities of both SUV39H1 and G9A for HMT activity. Figure 2A (Panel I) demonstrates that to an engineered zinc-finger transcription factor (VZ ϩ both the Suv Del 76 and G9A-ZFP chimeras have intrin-434 [12] , referred to here as ZFP-A). This engineered sic HMT activity, while control precipitations and those DNA binding protein specifically recognizes a site at utilizing extracts transfected with the ZFP DNA binding position ϩ434 relative to the transcription start site of domain alone did not precipitate HMTase activity. As the endogenous VEGF-A locus and has been shown has been previously reported, G9A is a significantly more previously to upregulate VEGF-A transcription when potent HMT than SUV39H1 in this assay [14] . A Western fused to the VP16 and p65 activation domains [12] . We, blot of the immunoprecipitates employed in the in vitro and others, have employed artificial zinc-finger DNA HMTase assay shown in Figure 2A (Panel II) confirms binding proteins to regulate a variety of endogenous that this difference in activity between the G9A and Suv genes in vivo (see [13] Figure 3A ). To recruit HDAC activity to the pro- 
ZFP-Driven Control of Endogenous Genes
We show here how novel ZFP transcription factors can ZFP fusions' ability to drive H3K9 methylation and the consequent transcriptional repression of the target be engineered to direct functional domains and/or catalytic activities to precise locations within the human gegene. These data present the first direct demonstration of a causal role for H3K9 methylation in endogenous nome to regulate endogenous gene expression. In contrast to a transient reporter gene assay, this unique chromosomal gene repression in vivo. Furthermore, the establishment of an H3K9 methylation pattern is shown capability allows the study of the molecular processes involved in both transcriptional regulation and in the to be a primary signal that is sufficient for initiating a gene repression pathway. Indeed, HMT-driven tranmodulation of chromatin structure directly on endogenous genes, i.e., within their native chromatin architecscriptional repression is likely to be conserved throughout all higher eukaryotes, since we observed that tarture. Furthermore, the direct targeting of enzymatic activities such as the H3K9 HMTs described here, able to geting these activities to the IGF2 and H19 genes achieved the transcriptional repression of these loci mark a region of chromatin for transcriptional silencing, provides both a powerful research tool and potential (data not shown) and that the Arabadopsis homolog of SUV39H1 was able to functionally repress the human therapeutic avenue in the study and treatment of human disease.
VEGF-A gene when fused to ZFP-A (A.W.S. and G. Li, unpublished data).

Experimental Procedures
In keeping with the in vitro substrate specificity of G9A and SUV39H1, we demonstrate that ZFP-HMT-mediated 
